Anavex Life Sciences Corp. Liquidation Value
AVXL
Other
Cash & Equivalents
$131.75M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $131.75M
Total Obligations: -$2.93M
$128.82M
Per share: $1.39
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $131.75M
AR: $700,000
Total Obligations: -$2.93M
$129.52M
Per share: $1.40
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $131.75M
AR: $700,000
Inventory: $0
Total Obligations: -$2.93M
$129.52M
Per share: $1.40
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $128.82M | $1.39 |
| Liquid Liquidation Value | $129.52M | $1.40 |
| Operating Liquidation Value | $129.52M | $1.40 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $131.75M |
| Accounts Receivable | $700,000 |
| Inventory | N/A |
| Current Liabilities | $2.93M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 92.7M |
Explore all 61 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $131.75M | $700,000 | N/A | $2.64M | N/A | N/A | N/A | N/A |
| 2025-09-30 | $102.58M | $700,000 | N/A | $4.25M | N/A | N/A | N/A | N/A |
| 2025-06-30 | $101.16M | $600,000 | N/A | $6.74M | N/A | N/A | N/A | N/A |
▼ Community Notes